Bio-Techne (TECH) Operating Leases (2019 - 2026)

Bio-Techne's Operating Leases history runs 8 years deep, the most recent figure standing at $76.1 million for Q1 2026.

• In Q1 2026, Operating Leases fell 4.16% year-over-year to $76.1 million; the TTM figure through Mar 2026 stood at $76.1 million (down 4.16% YoY), while the FY2025 annual figure was $84.0 million, down 4.17% from the prior year.
• Operating Leases for Q1 2026 stood at $76.1 million, down from $77.2 million in the prior quarter.
• The five-year high for Operating Leases was $97.3 million in Q3 2023, with the low at $56.3 million in Q1 2022.
• The 5-year median for Operating Leases is $81.6 million (2024), against an average of $81.3 million.
• The sharpest annual moves came in 2022 and 2023: Operating Leases retreated 15.67% in 2022, then surged 65.52% in 2023.
• Bio-Techne's Operating Leases stood at $78.2 million in 2022, then increased by 22.82% to $96.0 million in 2023, then fell by 15.01% to $81.6 million in 2024, then slipped by 5.43% to $77.2 million in 2025, then decreased by 1.35% to $76.1 million in 2026.
• Business Quant data shows TECH's Operating Leases at $76.1 million in Q1 2026, $77.2 million in Q4 2025, and $80.7 million in Q3 2025.